APA

Mathieu C., Barnett A. H., Brath H., Conget I., de Castro J. J., Göke R., Márquez Rodriguez E., Nilsson P. M., Pagkalos E., Penfornis A., Schaper N. C., Wangnoo S. K., Kothny W. & Bader G. (20140430). Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE). : International journal of clinical practice.

Chicago

Mathieu C, Barnett A H, Brath H, Conget I, de Castro J J, Göke R, Márquez Rodriguez E, Nilsson P M, Pagkalos E, Penfornis A, Schaper N C, Wangnoo S K, Kothny W and Bader G. 20140430. Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE). : International journal of clinical practice.

Harvard

Mathieu C., Barnett A. H., Brath H., Conget I., de Castro J. J., Göke R., Márquez Rodriguez E., Nilsson P. M., Pagkalos E., Penfornis A., Schaper N. C., Wangnoo S. K., Kothny W. and Bader G. (20140430). Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE). : International journal of clinical practice.

MLA

Mathieu C, Barnett A H, Brath H, Conget I, de Castro J J, Göke R, Márquez Rodriguez E, Nilsson P M, Pagkalos E, Penfornis A, Schaper N C, Wangnoo S K, Kothny W and Bader G. Effectiveness and tolerability of second-line therapy with vildagliptin vs. other oral agents in type 2 diabetes: a real-life worldwide observational study (EDGE). : International journal of clinical practice. 20140430.